An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer.

Lee A, Kang T, Kang SH, Park WC, Lim W, Chang MC, Kim HY, Song JY, Lee J, Byun KD, Kim HA, Son GS, Kim JY, Oh SJ, Chung MS, Choi YJ, Shin HJ, Baek JM, Yoo Y, Um E, Choi JH, Kwak BS, Park MH, Lee SH, Kim CS, Lee I, Kim JR, Lee HS, Lim CW

Open source

DOI: 10.1016/j.breast.2023.103585
Published: 2023 Dec
Container: Breast (Edinburgh, Scotland)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.breast.2023.103585,
  title = {An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer.},
  author = {Lee A and Kang T and Kang SH and Park WC and Lim W and Chang MC and Kim HY and Song JY and Lee J and Byun KD and Kim HA and Son GS and Kim JY and Oh SJ and Chung MS and Choi YJ and Shin HJ and Baek JM and Yoo Y and Um E and Choi JH and Kwak BS and Park MH and Lee SH and Kim CS and Lee I and Kim JR and Lee HS and Lim CW},
  year = {2023},
  journal = {Breast (Edinburgh, Scotland)},
  doi = {10.1016/j.breast.2023.103585},
  url = {https://doi.org/10.1016/j.breast.2023.103585}
}

RIS

TY  - JOUR
TI  - An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer.
AU  - Lee A
AU  - Kang T
AU  - Kang SH
AU  - Park WC
AU  - Lim W
AU  - Chang MC
AU  - Kim HY
AU  - Song JY
AU  - Lee J
AU  - Byun KD
AU  - Kim HA
AU  - Son GS
AU  - Kim JY
AU  - Oh SJ
AU  - Chung MS
AU  - Choi YJ
AU  - Shin HJ
AU  - Baek JM
AU  - Yoo Y
AU  - Um E
AU  - Choi JH
AU  - Kwak BS
AU  - Park MH
AU  - Lee SH
AU  - Kim CS
AU  - Lee I
AU  - Kim JR
AU  - Lee HS
AU  - Lim CW
PY  - 2023
JO  - Breast (Edinburgh, Scotland)
DO  - 10.1016/j.breast.2023.103585
UR  - https://doi.org/10.1016/j.breast.2023.103585
ER  -

APA

A, L., T, K., SH, K., WC, P., W, L., MC, C., HY, K., JY, S., J, L., KD, B., HA, K., GS, S., JY, K., SJ, O., MS, C., YJ, C., HJ, S., JM, B., Y, Y., E, U., JH, C., BS, K., MH, P., SH, L., CS, K., I, L., JR, K., HS, L., & CW, L. (2023). An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer.. Breast (Edinburgh, Scotland). https://doi.org/10.1016/j.breast.2023.103585

Source records

pubmed · retrieved 2026-09-26T17:11:03.621Z